RESPIRATORY TRACT INFECTION TREATMENT MARKET ANALYSIS

Regional Analysis

Respiratory Tract Infection Treatment Market- Regional Analysis

On the basis of region, the global respiratory tract infection treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position in the global respiratory tract infection treatment market over the forecast period, owing to increasing number of hospitalizations and emergency visits associated with acute or life threatening medical problems.

According to the study by Society of Critical Care Medicine 2016, over 5.7 million patients are admitted annually in intensive care units (ICUs) in the U.S. for support of airway, breathing or circulation, and comprehensive management of injury.

Also, according to the Centers for Disease Control and Prevention (CDC), 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were registered in the U.S. hospital facilities.

Furthermore, several pharmaceutical and biotechnological companies are focusing on expanding their business in Asia Pacific region, to maximize their R&D activities, as this region provides better access to patients for clinical trials, with low cost operational efficiencies. Increasing government investments in research and development, patient awareness, improved health care infrastructure and facilities, high disposable income, and prevalence of unhealthy lifestyle are also expected to foster growth of the respiratory tract infection treatment market in the Asia Pacific region.